FibroGen Inc (FGEN) – Company Profile and SWOT Analysis
- Pages: 53
- Published: November 2025
- Report Code: MLPH13844FSA
FibroGen Inc (FGEN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
FibroGen Inc (FibroGen) is a biopharmaceutical company focused on developing novel therapies in the fields of cancer biology and anemia. The company's main activities include the research and development of innovative treatments for life-threatening conditions such as metastatic pancreatic cancer, locally advanced pancreatic cancer, and chemotherapy-induced anemia. Major products under development include Pamrevlumab, a human monoclonal antibody, and Roxadustat, an oral small molecule inhibitor. FibroGen collaborates with partners like AstraZeneca and Astellas Pharma Inc. for the commercialisation of its products in various regions. The company's products are primarily targeted at healthcare providers and patients dealing with cancer and anemia-related conditions. FibroGen operates in multiple geographic locations, with a focus on markets in China, Europe, Japan, and other countries. FibroGen is headquartered in San Francisco, California, USA.
Scope
• Detailed information on FibroGen Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting FibroGen Inc in the form of a SWOT analysis
• An in-depth view of the business model of FibroGen Inc including a breakdown and examination of key business segments
• News about FibroGen Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of FibroGen Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess FibroGen Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on FibroGen Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Boehringer Ingelheim International GmbH
Akebia Therapeutics Inc
Bayer AG
Amgen Inc
3SBio Inc
Kyowa Kirin Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.